The Future Standard of
Therapeutic Medical Isotopes
Production and Supply

 

See our isotopes

What we do

We develop a unique technology concept to produce almost every medical isotope anywhere in the world and help shape the future of medical isotope production and supply.

Linear Accelerator Technologies

Unique concept of isotope production based on high-energy, high-current Linear accelerator. It allows to produce almost all rare and hard to procure therapeutic medical isotopes eliminating the need of reactor irradiation and creating flexibility for any future market needs. Development stage.

Target Technologies (accelerator/reactor)

Best of the class Target Technologies for accelerators and reactors with largest capacity and highest yields.

Physical and Chemical Separation Technologies Development

We are Experts in Separation Technologies with Physical Methods allowing to obtain outstanding yields and purity of isotopes on the market. We specialize in different mass separation technologies.

  • processing of large targets (patented)
  • highly advanced mass separation technologies
R&D outsource services provider for medical isotope production needs

You are stuck with a production problem, want to optimize your process or have an idea but not the manpower to develop it?

Our team of experts is at your service.

Isotope supply
  • You need a stable supply of Lu 177 and Ac 225. We are here to cover your needs
  • You are a startup or new in the business. We supply small quantities at preferable pricing to get you launched

We supply

Colibri offers complete solutions for your radiopharmaceutical production.

Therapeutic177
LuLutetium 177Read more

Today a very promisimg isotope, used in Lutetium-177 PSMA therapy, or Lutetium-177 prostatespecific membrane antigen therapy, a treatment for men with advanced prostate cancer.

Therapeutic225
AcActinium 225Read more

Despite its limited availability, another promising isotope. Several clinical trials have been completed, demonstrating the effectiveness of 225Ac in targeted alpha therapy. Complexes labeled with 225Ac have been tested to target various types of cancer, including leukemia, prostate carcinoma, and breast carcinoma in humans.

Please also send us an inquiry for any other isotope needs

Send inquiry

Colibri is a company driven by innovation. With our own research team working relentlessly, Colibri will develop from isotopes distribution to much more in the coming years.

I see a bright and exciting future ahead of us.

Olivier HolderbaumBusiness Development Director

Who we are

We are a team of like-minded, passionate professionals with the common goal of providing solutions to complex isotope production and supply problems.

Our team unites:

  • radiochemists
  • target construction physicists
  • particle accelerator specialists
  • accelerator physics experts
  • managing leads

Our team is inspired by Colibri traits which reflect the company attitude in business, research and development

Mindfulness
Independence
Creativity
Swiftness
OUR VISION

To develop state-of-the-art isotope production technologies enhancing the supply of quality medical isotopes accessible for everyone, elevating the standard of healthcare for patients around the world.

Our mission

For customers

We strive on fulfilling our customer’s needs by providing a stable isotopes supply, as well as developing and supplying technologies that allow to produce any kind of diagnostic and therapeutic isotopes on place, where and when they are needed. This empowers our customers, from researchers to clinicians, to achieve the best possible outcomes in drug research and patient care.

For employees

We provide a highly motivational work atmosphere complimentary to the ambitions and dreams of each employee.

For patients

We provide highest quality isotopes that allow for the best possible diagnostic and treatment.

Values
Safety

Ensuring the highest safety standards for our employees, patients, and the environment.

Fairness

Promoting fair treatment to foster win-win cooperation at all levels.

Collaboration and Partnership

Building long-term, dependable partnerships with clients and suppliers.

Fun & Innovation

Nurturing creativity through exciting and innovative R&D approaches.

Passion

Driven by passion to create a healthier world for all.

Courage

Empowering our team to overcome challenges on the road to success.

News and history

NewsFebruary2024
Colibri receives patent (U.S. Pat. No. 11,894,156)
Novelle target technology that allows to irradiate and process Yb-176 targets with masses of 2 to 50 gram.
NewsNovember2023
Morpho tests the Kalupso module at Colibri’s facility
Colibri supports Morpho in testing the first standard unit of KaLupso, a unique fully automatic Lu-177 processing equipment, at their facility in Lubbock. Ongoing.